Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Millard, J
Right arrow Articles by Ramsden, D B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Millard, J
Right arrow Articles by Ramsden, D B
Molecular Pathology 2003;56:270-274
© 2003 BMJ Publishing Group Ltd. & Association of Clinical Pathologists


ORIGINAL ARTICLE

Expression of cysteine dioxygenase (EC 1.13.11.20) and sulfite oxidase in the human lung: a potential role for sulfate production in the protection from airborne xenobiotica

J Millard1, R B Parsons2, R H Waring1, A C Williams3 and D B Ramsden2

1 School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
2 Department of Medicine, University of Birmingham
3 Neuroscience Centre, Queen Elizabeth Hospital, Birmingham B15 2TH.

Correspondence to:
Dr R B Parsons, Neurodegeneration Unit, Department of Medical Sciences (Surgery), St George’s Hospital Medical School, Cranmer Terrace, London SW17 ORE, UK;
r.parsons{at}sghms.ac.uk

Aims: The lung is one of the major sites of phase I cytochrome P450 enzyme and phase II sulfotransferase expression, which together are thought to act as an enzymic barrier against the unimpeded transfer of airborne xenobiotics into the lung parenchyma and systemic circulation. Sulfate for conjugation is produced primarily from the oxidation of cysteine, begun by cysteine dioxygenase (CDO), and completed with the conversion of sulfite to sulfate via sulfite oxidase (SO). Little is known about the site of expression of these two enzymes in the alveoli of the human lung.

Methods: Antibodies and oligonucleotide probes raised against both CDO and SO were used for immunohistochemistry and in situ hybridisation, respectively, to investigate the expression of CDO and SO in human lung alveoli.

Results: CDO and SO were expressed in alveolar epithelial cells, which is also the site of expression of cytochrome P450 1B1.

Conclusions: These results demonstrate that the two key enzymes in sulfate production are expressed in the same locale as phase I and phase II enzymes, and that these two enzymes may be involved in the production of sulfate for the maintenance of a metabolic barrier against the entry of airborne xenobiotics and the synthesis of important structural proteins and proteoglycans.


Keywords: cysteine dioxygenase; cytochrome P450; lung; alveoli; sulfation; sulfite oxidase

Abbreviations: CDO, cysteine dioxygenase; DAB, diaminobenzidine; PAP, peroxidase–antiperoxidase; PAPs, phosphoadenosine-5'-phosphosulfate; SO, sulfite oxidase




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Zhang, A. S. Vincent, B. Halliwell, and K. P. Wong
A Mechanism of Sulfite Neurotoxicity: DIRECT INHIBITION OF GLUTAMATE DEHYDROGENASE
J. Biol. Chem., October 8, 2004; 279(41): 43035 - 43045.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.